SOLIPHARM
Business purpose.
courtier aux achats en pharmacie, négoce gros-demi gros, prestations de services administratives, financières, techniques, soutien aux entreprises
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- Headcount unknown
- Created
- 28 May 2024
- Share capital
- 2,000.00 EUR
- Financial year end
- 31/12
- Establishments
- 1
Directors
- LYCORN CONSEIL President de SAS
Other companies at the same address
2 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
60 / 100 C
Confidence: medium · computed on the financial year ended 31 Dec 2025
- Equity to assets (36.2 %)
- 14.1 out of 30
- EBITDA margin (27.3 %)
- 19.9 out of 25
- Liquidity (214.1 %)
- 9.8 out of 20
- Debt (47.1 %)
- 9.8 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
85 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (2.5 years)
- 5.0 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2025 | 185,801 € | first year on record | 50,685 € | 41,937 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Legal notices
-
Filing of accounts 26 Jun 2026
- Court :
- Greffe du Tribunal de Commerce de la roche-sur-yon
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260120, annonce n 6190 · Proof of publication (PDF)
-
Incorporation 14 Jun 2024
- Court :
- Greffe du Tribunal de Commerce de la Roche-sur-Yon
BODACC A n 20240114, annonce n 1188 · Proof of publication (PDF)
Filings and accounts
- Formality 17 Feb 2025
- Formality 5 Jun 2024
Change history
- officer_appointed (empty) → President de SAS 9 Oct 2026
- capital (empty) → 2000.00 2 Oct 2026
Frequently asked questions about SOLIPHARM
- What is the SIREN number of SOLIPHARM?
- The SIREN number of SOLIPHARM is 929341360. Its intra-community VAT number is FR40929341360.
- Where is the head office of SOLIPHARM?
- Head office address: 85 CHEMIN DE MASSOTTE, 85300 SOULLANS.
- When was SOLIPHARM founded?
- SOLIPHARM was founded on 28 May 2024.
- What does SOLIPHARM do?
- Its declared main activity is: Wholesale (intercompany trade) of pharmaceutical goods (NAF code 46.46Z).
- Who runs SOLIPHARM?
- The officer listed in the register is LYCORN CONSEIL (President de SAS).
- What is the revenue of SOLIPHARM?
- The latest published revenue is 185,801 €, for the 2025 financial year.
- Is SOLIPHARM subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.